New England Journal of Medicine, volume 384, issue 10, pages 905-914
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
Publication type: Journal Article
Publication date: 2020-12-22
Journal:
New England Journal of Medicine
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 158.5
ISSN: 00284793, 15334406
PubMed ID:
33356051
General Medicine
Abstract
Abstract Background LY-CoV555, a neutralizing monoclonal antibody, has been associated with a decrease in viral load and the frequency of hospitalizations or emergency department visits among outpatients with coronavirus disease 2019 (Covid-19). Data are needed on the effect of this antibody in patients who are hospitalized with Covid-19. Methods In this platform trial of therapeutic agents, we randomly assigned hospitalized patients who had Covid-19 without end-organ failure in a 1:1 ratio to receive either LY-CoV555 or matching placebo. In addition, all the patients received high-quality supportive care as background therapy, including the antiviral drug remdesivir and, when indicated, supplemental oxygen and glucocorticoids. LY-CoV555 (at a dose of 7000 mg) or placebo was administered as a single intravenous infusion over a 1-hour period. The primary outcome was a sustained recovery during a 90-day period, as assessed in a time-to-event analysis. An interim futility assessment was performed on the basis of a seven-category ordinal scale for pulmonary function on day 5. Results On October 26, 2020, the data and safety monitoring board recommended stopping enrollment for futility after 314 patients (163 in the LY-CoV555 group and 151 in the placebo group) had undergone randomization and infusion. The median interval since the onset of symptoms was 7 days (interquartile range, 5 to 9). At day 5, a total of 81 patients (50%) in the LY-CoV555 group and 81 (54%) in the placebo group were in one of the two most favorable categories of the pulmonary outcome. Across the seven categories, the odds ratio of being in a more favorable category in the LY-CoV555 group than in the placebo group was 0.85 (95% confidence interval [CI], 0.56 to 1.29; P=0.45). The percentage of patients with the primary safety outcome (a composite of death, serious adverse events, or clinical grade 3 or 4 adverse events through day 5) was similar in the LY-CoV555 group and the placebo group (19% and 14%, respectively; odds ratio, 1.56; 95% CI, 0.78 to 3.10; P=0.20). The rate ratio for a sustained recovery was 1.06 (95% CI, 0.77 to 1.47). Conclusions Monoclonal antibody LY-CoV555, when coadministered with remdesivir, did not demonstrate efficacy among hospitalized patients who had Covid-19 without end-organ failure. (Funded by Operation Warp Speed and others; TICO ClinicalTrials.gov number, NCT04501978.)
Top-30
Citations by journals
|
2
4
6
8
10
12
|
|
|
Frontiers in Immunology
11 publications, 3.43%
|
|
|
Clinical Infectious Diseases
9 publications, 2.8%
|
|
|
Annals of Internal Medicine
5 publications, 1.56%
|
|
|
International Journal of Molecular Sciences
5 publications, 1.56%
|
|
|
Journal of Medical Virology
5 publications, 1.56%
|
|
|
Journal of Infectious Diseases
5 publications, 1.56%
|
|
|
Journal of Clinical Medicine
4 publications, 1.25%
|
|
|
Nature Communications
4 publications, 1.25%
|
|
|
The Lancet Infectious Diseases
4 publications, 1.25%
|
|
|
The Lancet Respiratory Medicine
4 publications, 1.25%
|
|
|
mBio
4 publications, 1.25%
|
|
|
Expert Opinion on Biological Therapy
4 publications, 1.25%
|
|
|
The Lancet
3 publications, 0.93%
|
|
|
Journal of Clinical Investigation
3 publications, 0.93%
|
|
|
Infectious Diseases and Therapy
3 publications, 0.93%
|
|
|
European Respiratory Journal
3 publications, 0.93%
|
|
|
Viruses
3 publications, 0.93%
|
|
|
Nature Reviews Immunology
3 publications, 0.93%
|
|
|
Nature
3 publications, 0.93%
|
|
|
Infection
3 publications, 0.93%
|
|
|
EBioMedicine
3 publications, 0.93%
|
|
|
PLoS ONE
3 publications, 0.93%
|
|
|
Clinical Microbiology Reviews
3 publications, 0.93%
|
|
|
Antimicrobial Agents and Chemotherapy
3 publications, 0.93%
|
|
|
Infectious Diseases in Clinical Practice
2 publications, 0.62%
|
|
|
Pharmaceuticals
2 publications, 0.62%
|
|
|
Pathogens
2 publications, 0.62%
|
|
|
Antibiotics
2 publications, 0.62%
|
|
|
Frontiers in Medicine
2 publications, 0.62%
|
|
|
2
4
6
8
10
12
|
Citations by publishers
|
10
20
30
40
50
60
|
|
|
Elsevier
59 publications, 18.38%
|
|
|
Springer Nature
47 publications, 14.64%
|
|
|
Wiley
27 publications, 8.41%
|
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
25 publications, 7.79%
|
|
|
Cold Spring Harbor Laboratory
25 publications, 7.79%
|
|
|
Oxford University Press
21 publications, 6.54%
|
|
|
Frontiers Media S.A.
18 publications, 5.61%
|
|
|
Taylor & Francis
13 publications, 4.05%
|
|
|
American Society for Microbiology
12 publications, 3.74%
|
|
|
BMJ
7 publications, 2.18%
|
|
|
Wolters Kluwer Health
6 publications, 1.87%
|
|
|
American College of Physicians
5 publications, 1.56%
|
|
|
Public Library of Science (PLoS)
5 publications, 1.56%
|
|
|
American Society for Clinical Investigation
4 publications, 1.25%
|
|
|
European Respiratory Society (ERS)
3 publications, 0.93%
|
|
|
Baishideng Publishing Group
3 publications, 0.93%
|
|
|
Thieme
3 publications, 0.93%
|
|
|
NEJM Group
2 publications, 0.62%
|
|
|
SAGE
2 publications, 0.62%
|
|
|
American Association for Cancer Research (AACR)
2 publications, 0.62%
|
|
|
American Society of Hematology
2 publications, 0.62%
|
|
|
American Thoracic Society
1 publication, 0.31%
|
|
|
F1000 Research
1 publication, 0.31%
|
|
|
Impact Journals
1 publication, 0.31%
|
|
|
JMIR Publications
1 publication, 0.31%
|
|
|
Japanese Society of Internal Medicine
1 publication, 0.31%
|
|
|
Diabetes Technology Society
1 publication, 0.31%
|
|
|
AACN Publishing
1 publication, 0.31%
|
|
|
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
1 publication, 0.31%
|
|
|
10
20
30
40
50
60
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2020,2021,2022,2023,2024],"ids":[0,0,0,0,0],"codes":[0,0,0,0,0],"imageUrls":["","","","",""],"datasets":[{"label":"Citations number","data":[2,128,111,52,28],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["0.62","39.88","34.58","16.2","8.72"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Frontiers in Immunology","Clinical Infectious Diseases","Annals of Internal Medicine","International Journal of Molecular Sciences","Journal of Medical Virology","Journal of Infectious Diseases","Journal of Clinical Medicine","Nature Communications","The Lancet Infectious Diseases","The Lancet Respiratory Medicine","mBio","Expert Opinion on Biological Therapy","The Lancet","Journal of Clinical Investigation","Infectious Diseases and Therapy","European Respiratory Journal","Viruses","Nature Reviews Immunology","Nature","Infection","EBioMedicine","PLoS ONE","Clinical Microbiology Reviews","Antimicrobial Agents and Chemotherapy","Infectious Diseases in Clinical Practice","Pharmaceuticals","Pathogens","Antibiotics","Frontiers in Medicine"],"ids":[1699,6688,5979,14627,22523,23302,26234,3231,7334,24864,9121,10768,12510,1384,19665,24322,2455,10916,14611,2510,23878,24963,8942,17567,8164,1203,20044,1488,17043],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/yNSijlgQghQF53VZuyFLA30CKDe4j3HK74Vtpnxa_medium.webp","\/storage\/images\/resized\/Lt8Bjvw15DwKGPCOmQGiszAAhxutsp9iq5eT4wNr_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/yNSijlgQghQF53VZuyFLA30CKDe4j3HK74Vtpnxa_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/aFa86lAy63Pq5tYKiOsH017UsgJA6uk6ed66C0Ns_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/hMjtEcPnOlZu0Qdup5ZFVJML9APp6JeBF0xfZC5e_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/PRGhlgB4OKRltSNtT39eA6wlnOTGRap1QQ6FQHih_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/6QE8LXWrLpkoy5A2te6hw7who46GeCoTYIstuoAz_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp"],"datasets":[{"label":"","data":[11,9,5,5,5,5,4,4,4,4,4,4,3,3,3,3,3,3,3,3,3,3,3,3,2,2,2,2,2],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[3.43,2.8,1.56,1.56,1.56,1.56,1.25,1.25,1.25,1.25,1.25,1.25,0.93,0.93,0.93,0.93,0.93,0.93,0.93,0.93,0.93,0.93,0.93,0.93,0.62,0.62,0.62,0.62,0.62],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Elsevier","Springer Nature","Wiley","Multidisciplinary Digital Publishing Institute (MDPI)","Cold Spring Harbor Laboratory","Oxford University Press","Frontiers Media S.A.","Taylor & Francis","American Society for Microbiology","BMJ","Wolters Kluwer Health","American College of Physicians","Public Library of Science (PLoS)","American Society for Clinical Investigation","European Respiratory Society (ERS)","Baishideng Publishing Group","Thieme","NEJM Group","SAGE","American Association for Cancer Research (AACR)","American Society of Hematology","American Thoracic Society","F1000 Research","Impact Journals","JMIR Publications","Japanese Society of Internal Medicine","Diabetes Technology Society","AACN Publishing","International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)"],"ids":[17,8,11,202,6909,19,208,18,142,6954,32,2056,344,564,3289,7719,135,2929,31,2286,2252,3246,7910,342,7126,7759,5839,8668,1481],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/hg4jJjT8wVGtHstBCc0zk465Mg9pLx3G4odCDOqE_medium.webp","\/storage\/images\/resized\/yNSijlgQghQF53VZuyFLA30CKDe4j3HK74Vtpnxa_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/hysFKdIDQMKHPbF1uLxJ3M6dQA4gPVuC6ZeA7m5a_medium.webp","\/storage\/images\/resized\/6QE8LXWrLpkoy5A2te6hw7who46GeCoTYIstuoAz_medium.webp","\/storage\/images\/resized\/Lt8Bjvw15DwKGPCOmQGiszAAhxutsp9iq5eT4wNr_medium.webp","\/storage\/images\/resized\/PRGhlgB4OKRltSNtT39eA6wlnOTGRap1QQ6FQHih_medium.webp","\/storage\/images\/resized\/aFa86lAy63Pq5tYKiOsH017UsgJA6uk6ed66C0Ns_medium.webp","\/storage\/images\/resized\/hMjtEcPnOlZu0Qdup5ZFVJML9APp6JeBF0xfZC5e_medium.webp","\/storage\/images\/resized\/bKOjgSt9mSGUD9fzKZyqcKSIgDCDSMd1ZWjJOZzx_medium.webp","\/storage\/images\/resized\/xqixcltwJYe6H8Uco2JbAFfIOzt7UNKH0OcPOPzO_medium.webp","\/storage\/images\/resized\/zERSCvSmqNPcErreyd1xoLNnZOn7FU7lakrxwchY_medium.webp","\/storage\/images\/resized\/ruydfaB80LDjlkYqsfOeUAZohOIODyq7bQzis5O7_medium.webp","\/storage\/images\/resized\/cfuVw6XIq2mATDNJdXiose3W8qYbkmaVSpHoP8XL_medium.webp","\/storage\/images\/resized\/QMhhcrIUiVtFnND3WWZ7hIbu6GYeoRoA2zoVsMEX_medium.webp","\/storage\/images\/resized\/y6coX2RdMAMXy0PTXCMVDlJvumyjAcjbT7WXoxjx_medium.webp","\/storage\/images\/resized\/WEXVM2IukNfkmwoqmPhtMKmAeERljKWAbbXmEX7m_medium.webp","\/storage\/images\/resized\/HY0CXgRt044tzIAB16PDvDzdHeKHGtSvlMH0yWf6_medium.webp","\/storage\/images\/resized\/cRMehae9HOl9IXrL0Y5aSxEgqjYPaMefZzmyZtW8_medium.webp","\/storage\/images\/resized\/U6hP0c46iGbhhmI573ENh7o8Fpypf16yMD5Etn7B_medium.webp","\/storage\/images\/resized\/3Zxmhu9KltEoorwnMY4vX43mpeIDJ3W9xFln236C_medium.webp","\/storage\/images\/resized\/yuwwsSqw0Jpfb202jzIt1jAda7Liw7ODV2fbN4Fh_medium.webp",""],"datasets":[{"label":"","data":[59,47,27,25,25,21,18,13,12,7,6,5,5,4,3,3,3,2,2,2,2,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[18.38,14.64,8.41,7.79,7.79,6.54,5.61,4.05,3.74,2.18,1.87,1.56,1.56,1.25,0.93,0.93,0.93,0.62,0.62,0.62,0.62,0.31,0.31,0.31,0.31,0.31,0.31,0.31,0.31],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":false}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"yearsCitationsQuartiles":{"type":"bar","data":{"show":true,"labels":[2020,2021,2022,2023,2024],"ids":[],"codes":[],"imageUrls":[],"datasets":[{"label":"Q4","backgroundColor":"rgb(221,90,78)","data":[0,3,4,0,0],"percentage":["0","0.93","1.25","0","0"]},{"label":"Q3","backgroundColor":"rgb(251, 163,83)","data":[0,2,2,1,0],"percentage":["0","0.62","0.62","0.31","0"]},{"label":"Q2","backgroundColor":"rgb(232, 213, 89)","data":[0,10,16,6,2],"percentage":["0","3.12","4.98","1.87","0.62"]},{"label":"Q1","backgroundColor":"rgb(164, 207, 99)","data":[0,88,80,32,19],"percentage":["0","27.41","24.92","9.97","5.92"]},{"label":"Quartile not defined","backgroundColor":"#E5E7EB","data":[2,25,9,13,7],"percentage":["0.62","7.79","2.8","4.05","2.18"]}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":true},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":true}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations quartiles by SCImago per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"yearsCitationsQuartilesWs":{"type":"bar","data":{"show":true,"labels":[2020,2021,2022,2023,2024],"ids":[],"codes":[],"imageUrls":[],"datasets":[{"label":"Q4","backgroundColor":"rgb(221,90,78)","data":[0,3,3,1,0],"percentage":["0","0.93","0.93","0.31","0"]},{"label":"Q3","backgroundColor":"rgb(251, 163,83)","data":[0,5,6,3,1],"percentage":["0","1.56","1.87","0.93","0.31"]},{"label":"Q2","backgroundColor":"rgb(232, 213, 89)","data":[0,21,21,12,3],"percentage":["0","6.54","6.54","3.74","0.93"]},{"label":"Q1","backgroundColor":"rgb(164, 207, 99)","data":[0,69,65,21,17],"percentage":["0","21.5","20.25","6.54","5.3"]},{"label":"Quartile not defined","backgroundColor":"#E5E7EB","data":[2,30,16,15,7],"percentage":["0.62","9.35","4.98","4.67","2.18"]}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":true},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"},"stacked":true}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations quartiles by WoS per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.